SEC Form 4 · accession 0001415889-17-000947
Medovex Corp. · MDVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Gorlin
Director
Period of report
Jun 7, 2017
Accepted (ET)
Jun 8, 2017 · 10:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001591165
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 7, 2017 | P | 5,000 | $0.94 | A | 1,345,020 | D | |
| Common StockF1,F2 | Jun 7, 2017 | P | 15,000 | $0.95 | A | 1,360,020 | D | |
| Common StockF1,F2 | Jun 7, 2017 | P | 5,000 | $0.96 | A | 1,365,020 | D | |
| Common StockF1,F2 | Jun 7, 2017 | P | 5,000 | $0.98 | A | 1,370,020 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares purchased trade publicly under the symbol "MDVX" on the NASDAQ Capital Market.
- F2Includes 125,000 shares held by Mr. Gorlin's spouse, Deborah Gorlin. Mr. Gorlin disclaims beneficial ownership of Deborah Gorlin's shares.